CATHERINE DIAZ: Open Payments
NPI 1548850076 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,776 in 114 payments from 20 companies in 2025. Trend: 2023 $1,202 · 2024 $1,758 · 2025 $1,776
Food & beverage: $1,676Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 20 | $281 |
| ABBVIE INC. | 24 | $240 |
| Novartis Pharmaceuticals Corporation | 8 | $170 |
| Janssen Biotech, Inc. | 7 | $156 |
| Galderma Laboratories, L.P. | 16 | $139 |
| Mallinckrodt Hospital Products Inc. | 4 | $111 |
| LEO Pharma Inc. | 5 | $95 |
| E.R. Squibb & Sons, L.L.C. | 3 | $89 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
Products named: Bimzelx, TREMFYA, SKYRIZI, COSENTYX, NEMLUVIO, ACTHAR, ANZUPGO, Sotyktu.
Industry payments across MS — which companies pay providers there.
